Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Colorectal cancer is a malignant tumor originating from the epithelial cells of the colon or rectum and is one of the cancers of the digestive system. It often develops from adenomatous polyps, progresses slowly, and has inconspicuous early symptoms, making it easily overlooked. The disease mainly affects middle-aged and elderly people over 50, but in recent years it has shown a trend toward younger onset. With changes in diet structure and westernized lifestyles, the risk of incidence is increasing. If not detected early, colorectal cancer may invade the liver, lungs, and other organs, threatening life. Fortunately, if detected and treated early, the cure rate is relatively high.
Colorectal cancer is highly prevalent in developed Western countries, especially in the United States, Germany, and Japan, where its incidence ranks among the highest of all cancers. In recent years, the number of cases in East Asian countries such as China and South Korea has grown rapidly, likely related to high-fat diets and sedentary lifestyles. Globally, colorectal cancer shows a steady upward trend.
1. Strong Concealment, Difficult to Detect Early
Early-stage colorectal cancer may have no obvious symptoms, manifesting only as mild bloating or changes in bowel habits, which are easily overlooked. Once symptoms such as bloody stools, anemia, and abdominal pain occur, it is often already in the middle to late stage.
2. Local Invasion, Multiple Complications
As the tumor develops, it may invade the intestinal wall or nearby organs, causing complications such as intestinal obstruction, perforation, and bleeding. This increases treatment difficulty and significantly impacts quality of life.
3. High Metastatic Potential, Poor Prognosis
Advanced colorectal cancer often metastasizes through the blood or lymphatic system to vital organs such as the liver and lungs. Treatment is complex, and survival time is significantly shortened. Multidisciplinary treatment is usually required at this stage.
4. Heavy Psychological and Economic Burden
The long treatment process places enormous psychological pressure on patients and imposes a heavy economic burden on families, especially when managing recurrence and metastasis over extended periods.
Immune reconstruction cell therapy, a personalized precision treatment that has gradually emerged in recent years, is bringing new hope to colorectal cancer patients. By activating and enhancing the patient’s own immune cells to recognize and destroy cancer cells, this therapy can control tumor growth and delay recurrence. Advantages include reducing toxic side effects of traditional treatments, improving tolerance, and extending long-term survival, especially for patients who do not respond well to conventional therapies.
In practice, because cancer patients often face immune dysfunction, increased infection risks, and slow recovery when undergoing surgery, chemotherapy, or radiotherapy, it is necessary to scientifically design phased immune reconstruction programs to support treatment, improve tolerance, and enhance quality of life.
● Short-term Plan: Quickly enhance immunity through immune cell reinfusion to improve the effectiveness of anti-cancer treatment.
● Mid-term Plan: Reduce the side effects of traditional treatments, promote physical recovery, and ensure completion of standard treatment courses.
● Long-term Plan: Comprehensive immune reconstruction including immune cell, intestinal, elemental, and nutritional immunity to strengthen overall immune function, improve quality of life, and extend survival time.
1. Surgical Resection
For early-stage colorectal cancer, surgery is the first choice. Common procedures include local tumor resection and total colectomy. Postoperative adjuvant chemotherapy may be applied depending on pathology results. Surgery effectively controls the primary lesion and improves cure rates.
2. Chemotherapy
For advanced or postoperative patients, chemotherapy helps eliminate residual cancer cells and prevents metastasis and recurrence. Combination regimens based on fluorouracil and oxaliplatin are widely used with proven efficacy.
3. Radiotherapy
Radiotherapy plays an important adjuvant role, especially for rectal cancer patients. Preoperative radiotherapy can shrink tumors and increase surgical success rates; postoperative radiotherapy helps control residual or recurrent lesions.
4. Minimally Invasive Treatment Options
Currently, laparoscopic surgery and robotic-assisted minimally invasive resections cause less trauma and allow faster recovery. These approaches have gradually become mainstream for early colorectal cancer and are increasingly adopted as first-line treatment options by medical centers.
The concealed and metastatic nature of colorectal cancer makes it a major threat to global health. Active prevention and scientific treatment are crucial to disease control. Experts at United Life International Medical Center emphasize attention to emerging approaches such as immune reconstruction cell therapy, which may offer patients better treatment experiences and improved survival possibilities.
